HCC
ACLS icon

Hirtle Callaghan & Co’s Axcelis ACLS Stock Holding History

Hirtle Callaghan & Co’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-15
Closed – – 615
2013
Q3 		$0 Buy
+15
New +$122 ﹤0.01% 624

Other funds holding ACLS

DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Schneider Capital Management Berwyn, Pennsylvania $175M AUM 42.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Hirtle Callaghan & Co's ACLS Position: Q4 2013 in Review

Hirtle Callaghan & Co sold out of Axcelis (ACLS) in Q4 2013, closing a stake of 15 shares.

Hirtle Callaghan & Co first reported a position in ACLS in Q3 2013 and held it in 1 quarter. The position peaked at $0 in Q3 2013. 108 funds tracked by Wall St. Rank hold ACLS as of Q4 2013.

  • Hirtle Callaghan & Co reported no remaining Axcelis position as of Q4 2013 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 15 Axcelis shares in Q4 2013.
  • Hirtle Callaghan & Co first reported a position in Axcelis in Q3 2013 and held it in 1 quarter.
  • Hirtle Callaghan & Co's Axcelis position peaked at $0 in Q3 2013.
  • 108 funds tracked by Wall St. Rank held Axcelis as of Q4 2013.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2013, filed 29 Jan 2014.